MiR-652-3p promotes bladder cancer migration and invasion by targeting KCNN3

Q-L Zhu1, D-M Zhan, Y-K Chong

  • 1Department of Urology Surgery, Jiangdu People's Hospital of Yangzhou, Yangzhou, P.R. China. qingliang_zhu@126.com.

Abstract

Insights

MicroRNA miR-652-3p promotes bladder cancer (BCa) progression by upregulating KCNN3. Targeting miR-652-3p offers a potential therapeutic strategy for BCa treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • MicroRNAs (miRNAs) are key regulators in cancer development.
  • Bladder cancer (BCa) poses a significant global health challenge.
  • Understanding specific miRNA roles is crucial for BCa research.

Purpose of the Study:

  • To investigate the role of miR-652-3p in bladder cancer.
  • To elucidate the underlying molecular mechanisms of miR-652-3p in BCa.
  • To identify potential therapeutic targets for BCa.

Main Methods:

  • Real-Time quantitative Polymerase Chain Reaction (RT-qPCR) for miRNA expression analysis.
  • In vitro assays (CCK-8, wound-healing, transwell invasion) to assess cell behavior.
  • Luciferase reporter assays and rescue experiments to determine molecular targets and mechanisms.

Main Results:

  • miR-652-3p expression was significantly upregulated in BCa tissues and cell lines.
  • Downregulation of miR-652-3p suppressed BCa cell proliferation, migration, and invasion.
  • KCNN3 was identified as a direct functional target of miR-652-3p, with inverse correlation in BCa tissues.

Conclusions:

  • miR-652-3p promotes bladder cancer cell proliferation, migration, and invasion by directly regulating KCNN3.
  • miR-652-3p represents a potential novel therapeutic target for bladder cancer treatment.